Search company, investor...

Caliber Imaging & Diagnostics

caliberid.com

Founded Year

1991

Stage

IPO | IPO

Date of IPO

12/30/2011

About Caliber Imaging & Diagnostics

Caliber Imaging & Diagnostics, formerly Lucid, aims to provide dermatologists its VivaScope confocal imagers - the highest resolution commercially available medical skin imaging device - to assist them in quickly forming a clinical judgment regarding difficult skin conditions. Lucid is providing improved care for dermatology patients by coupling its noninvasive VivaScope cellular imagers with its VivaNet medical information system to allow secure, HIPAA compliant, near real-time collaboration between dermatologists and other medical specialists. The VivaNet system aims to provide rapid online medical image transfer, storage, and retrieval to enable these critical collaborative consultations. The technologies delivered by Lucid provide images that physicians use in forming critical clinical judgments in cases of dermatologic conditions, while ensuring patient comfort and piece of mind. This patented technology, routinely in use at leading medical centers around the World, aims to provide extremely high, cellular resolution images of a patient's skin. Due to the completion of clinical studies in Europe and Australia, deployment of their technology in dermatology clinics is already underway in these regions. Large clinical trials now underway in the United States should allow widespread deployment to begin in the U.S. in 2009. Lucid, Inc. is based in Rochester, New York (USA) with offices in North America, Europe, and Australia.

Headquarters Location

95 Methodist Hill Suite 500

Rochester, New York, 14623,

United States

585-239-9806

Missing: Caliber Imaging & Diagnostics's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Caliber Imaging & Diagnostics's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Caliber Imaging & Diagnostics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Caliber Imaging & Diagnostics is included in 2 Expert Collections, including Medical Devices.

M

Medical Devices

11,641 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health IT

7,901 items

Caliber Imaging & Diagnostics Patents

Caliber Imaging & Diagnostics has filed 1 patent.

The 3 most popular patent topics include:

  • Microscopy
  • Microscopes
  • Optical devices
patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/26/2019

3/22/2022

Microscopy, Medical imaging, Histology, Cell imaging, Interferometry

Grant

Application Date

2/26/2019

Grant Date

3/22/2022

Title

Related Topics

Microscopy, Medical imaging, Histology, Cell imaging, Interferometry

Status

Grant

Latest Caliber Imaging & Diagnostics News

Report [2019-2026], Video Dermatoscope Market Size, Share, Revenue, Growth, Trends, Competitive Landscape, Forecast by Fortune Business Insights™

Oct 12, 2020

Key Companies Covered in the Video Dermatoscope Market Research Report Are Caliber Imaging & Diagnostics, Dynamify GmbH, DermoScan GmbH, Firefly Global, FotoFinder Systems, Inc., HEINE Optotechnik GmbH & Co. KG, Adamo srl., NIDEK CO., LTD., Optomed Plc. and other key market players | Source: Fortune Business Insights Pune, Oct. 12, 2020 (GLOBE NEWSWIRE) -- The global video dermotoscope market size is expected to showcase a considerable growth owing to the increasing prevalence of melanoma and the growing adoption of technology by the manufacturers to develop advanced video dermatoscope devices across the globe. This information is published by Fortune Business Insights, in its upcoming report, titled, “Video Dermatoscope Market Size, Share & Industry Analysis, By Products (Mercury Video Dermatoscope, Aneroid Video Dermatoscope, Digital Video Dermatoscope), By Operations (Manual, Electric, Automatic, Semi-Automatic), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others) and Regional Forecast, 2019-2026.” A video dermatoscope is a medical device that is used to diagnose and assess several skin diseases such as skin lesions, skin cancer, and psoriasis. These devices take digital images stored and evaluated in the form of images. Additionally, these devices are extensively adopted to assess minute details before and after performing plastic surgery by the surgeon. Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/video-dermatoscope-market-103114 What does the Report Include? The market report includes quantitative and qualitative analysis of several factors such as the key drivers and restraints that will impact growth. Additionally, the report provides insights into the regional analysis that covers different regions, which are contributing to the growth of the market. It includes the competitive landscape that involves the leading companies and the adoption of strategies by them to introduce new products, announce partnerships, and collaboration that will further contribute to the growth of the market between 2019 and 2026. Moreover, the research analyst has adopted several research methodologies such as PESTEL and SWOT analysis to extract information about the current trends and industry developments that will drive the market growth in the forthcoming years. The widespread effect of the global pandemic, COVID-19, has been felt across several economies that are facing unprecedented loss. Owing to the lockdown announced by the government agencies to curb the spread of the novel coronavirus, several industries have been on a standstill with zero operational activities. However, a collective effort from the government, as well as the industries is anticipated to bring the economy back on track and aid in resuming industrial activities. Click here to get the short-term and long-term impact of COVID-19 on this Market. Increasing Incidence of Melanoma to Promote Growth According to the American Melanoma Foundation, about 9,500 people are estimated to be diagnosed with skin cancer every day in the U.S. The cases are expected to further rise by about 70% over the next two decades. The increasing prevalence of skin diseases is anticipated to propel the demand for advanced video dermatoscope devices across the globe. In addition to this, the adoption of technology in the medical field such as telemedicine is expected to bode well for the growth of the global video dermatoscope market in the forthcoming years. North America to Remain Dominant; Presence of Established Healthcare Infrastructures to Stoke Demand Among all the regions, North America is expected to be at the forefront and hold the highest position in the global video dermatoscope market during the forecast period. This dominance is attributable to the presence of established healthcare infrastructures and the increasing prevalence of skin diseases that propels the demand for advanced video dermatoscope in the region. The market in Asia-Pacific is anticipated to showcase a considerable growth during the forecast period. This is ascribable to factors such as the increasing adoption of innovative medical devices such as video dermatoscope in the region between 2019 and 2026. Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/video-dermatoscope-market-103114 Major Companies Launch Advanced Product to Expand Their Product Portfolio The global video dermatoscope market comprises of several small, medium, and large companies that are striving to maintain their presence by introducing advanced video dermatoscope devices and further expand their product portfolio. The adoption of strategies such as merger and acquisition, partnership, and collaboration by key players to strengthen their market positions is expected to contribute to the market growth in the forthcoming years. Industry Development: March 2020 – FotoFinder Systems, Inc. announced the launch of new automated total body mapping. According to the company, the total body video dermatoscope device enables an immediate assessment of dermoscopic structures of moles formed on the body. List of the Companies Operating in the Market: Caliber Imaging & Diagnostics Adamo srl. •              Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific) •              Latin America (Brazil, Mexico, Rest of Latin America) •              Middle East & Africa (South Africa, GCC, and Rest of the Middle East & Africa) Have a Look at Related Reports: Cardiovascular Devices Market Share and Industry Analysis, By Device Type (Diagnostic and Monitoring Devices, and Therapeutic and Surgical Devices), By Application (Coronary Artery Disease (CAD), Cardiac Arrhythmia, Heart Failure, and Others), By End User (Hospitals, Specialty Clinics, and Others), and Regional Forecast, 2019-2026 Ostomy/Stoma Care and Accessories Market Share & Industry Analysis, By Product [Ostomy Bags (One-piece and Two-piece) and Accessories], By Procedure (Colostomy, Ileostomy, and Urostomy), By End User (Hospitals, Home Care, and Specialty Clinics) and Regional Forecast, 2019-2026 Contract Development and Manufacturing Organization (CDMO) Market Share & Industry Analysis, By Service {By CMO (API, Finished Product {Solid Dosage Forms, Injectables, and Others}, and Packaging)} {By CRO (Discovery, Preclinical, Clinical Trial, and Laboratory Services)} and Regional Forecast, 2019-2026 Cosmeceuticals Market Share & Industry Analysis, By Product (Skin Care, Hair Care, Injectables and Others), By Distribution Channels (Pharmacy/Drug Stores, Online Stores, and Others), and Regional Forecast, 2019-2026 Neuromodulation Devices Market Share & Industry Analysis, By Product Type (Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Vagus Nerve Stimulators (VNS), Sacral Nerve Stimulators (SNS), Transcranial Magnetic Stimulators (TMS)), By Type (Invasive, and Non-invasive), By Application (Pain Management, Neurological Disorders, Respiratory Disorders), By End User (Hospitals, and Specialty Clinics), and Regional Forecast, 2019-2026 About Us: Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in. Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data. At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges. Contact Us: 308, Supreme Headquarters,

Caliber Imaging & Diagnostics Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Caliber Imaging & Diagnostics Rank

Caliber Imaging & Diagnostics Frequently Asked Questions (FAQ)

  • When was Caliber Imaging & Diagnostics founded?

    Caliber Imaging & Diagnostics was founded in 1991.

  • Where is Caliber Imaging & Diagnostics's headquarters?

    Caliber Imaging & Diagnostics's headquarters is located at 95 Methodist Hill, Rochester.

  • What is Caliber Imaging & Diagnostics's latest funding round?

    Caliber Imaging & Diagnostics's latest funding round is IPO.

  • Who are the investors of Caliber Imaging & Diagnostics?

    Investors of Caliber Imaging & Diagnostics include NYSTAR and Empire State Development.

  • Who are Caliber Imaging & Diagnostics's competitors?

    Competitors of Caliber Imaging & Diagnostics include Enspectra Health, InterRad Medical, Endologix, ArraVasc, Triangle Biosystems and 16 more.

Compare Caliber Imaging & Diagnostics to Competitors

S
Satiety

Satiety, Inc. is a medical device company focused on the development of less invasive devices for the treatment of obesity. Obesity is a global health problem, affecting 70 million people in the U.S. and 300 million worldwide, and growth of which is causing increases in obesity-related diseases such as diabetes, high blood pressure and cardiovascular disease. Obesity surgery has been shown to be the only long-term effective means of weight loss for morbidly obese patients. Satiety's first product, the TOGA System, enables physicians to perform a procedure similar to traditional restrictive obesity surgeries, but without surgical incisions. In this procedure, the TOGA System devices are inserted transorally (through the mouth) and are used to reduce the capacity of the stomach to give patients a feeling of fullness after a small meal. The procedure is intended to be safer and easier for patients to tolerate than conventional obesity surgery. Safety and effectiveness of the TOGA System are currently being evaluated in a multi-center U.S. Study and the system is not available for sale in the United States.

V
Varix Medical

Varix Medical Corporation, located in Sunnyvale, Calif., is a medical device company focused on developing products for the minimally invasive treatment of chronic venous insufficiency, commonly referred to as "varicose veins." For patients with advanced stages of varicose veins, laser- and RF-based (radiofrequency) treatments have been developed, but each device has deficiencies making them less-than-optimal solutions. Varix Medical's platform technology will enable physicians to efficiently and effectively treat more types of diseased veins than is currently possible when using either laser or RF devices. Additional treatable vessels include tortuous sub-truncal vessels and other visible smaller varicose veins. The Varix platform employs a vapor-based endovenous ablation system that will consist of a disposable catheter, a catheter introducer or delivery system, and a reusable vapor generator. RCT and Coronis Medical Ventures LLC., formed Varix in August 2007 and acquired the technology under license from Tsunami MedTech LLC. Coronis and RCT have been the primary in investors in Varix.

OrthAlign Logo
OrthAlign

OrthAlign provides orthopedic surgeons with user-friendly and cost-effect technology for precise alignment.

C
Coromedic

Coromedic is a privately owned biomedical start up company working to manufacture devices and develop techniques to facilitate coronary artery bypass surgery in a minimally invasive technique. The company's flagship products, the proximal anastomosis device, the distal anastomosis device and the internal mammary artery harvester are a in a set of invaluable tools aimed at easing the complications associated with the conventional surgery. The company have worked to design and build prototypes of the company's products and develop a business strategy, consulting with numerous professionals to assess the feasibility and utility of the company's product and business model. The process of idea protection and patent application is ongoing, a provisional patent for one of the company's products, the proximal anastomosis devices is in place and the application for patent protection of all the company's products is underway. The prototype of the company's first device, the proximal anastomosis device is built and tested in the wet lab. The company are currently working on prototype assembly of the company's second and third products, after which lab animal experiments in the appropriate facilities will take place and then approval for clinical trials and their undertaking will commence.

W
Wioptix

Wioptix is a company that received a SBIR Phase IB grant for a project entitled: Development of Miniature Endoscopic Imaging Probes for In Vivo Noninvasive Optical Imaging for Early Diagnosis of Lung Cancer. Their Phase I project an Optical coherence tomography (OCT) imaging MEMS-based probe of 2.8 mm diameter will be designed and manufactured. The plan is to apply MEMS design and wire bonding free packaging techniques for miniaturization of the probe. In this MEMS design the mirror will have high fill factor and bonding pads on the opposite chip side of the reflective mirror surface. The MEMS mirror and the other optical component will be packaged into the MEMS-based probe; the probe will be attached with the existing OCT system, and then will be tested for lung imaging. The proposed MEMS-based OCT system has the potential to be a low-cost tool for rapid diagnosis or screening of lung cancer at the point of care. It is also expected that the technology could be used for other OCT systems for internal organ imaging. If successful the proposed MEMS design and wire bonding-free (WBF) packaging technique can be applied virtually to all optical imaging systems including coherence, confocal, nonlinear and adaptive optical imaging. They can also be used in laser scanning displays and optical telecommunications. This effort may lead to the world's first MEMS-based OCT applicable to rapid diagnosis or screening of lung cancer at the point of care (e.g., bedside or office). Due to its low-cost and disposable nature, it is particularly suitable for field use without the need of sterilization equipments. Although the focus of this proposal is on a MEMS based endoscopic OCT system for bronchoscopy, the key technology developed can be adapted for other compact OCT systems for internal organ imaging. The MEMS-based endoscopic OCT probe is applicable to diagnosis and image-guided surgery of various internal cancers such as prostate, colon, rectal, and gastro-intestinal cancers. Wioptix is a company that received a SBIR Phase I grant for a project entitled: Development of Miniature Endoscopic Imaging Probes for In Vivo Noninvasive Optical Imaging for Early Diagnosis of Lung Cancer. Their Phase I project an Optical coherence tomography (OCT) imaging MEMS-based probe of 2.8 mm diameter will be designed and manufactured. The plan is to apply MEMS design and wire bonding free packaging techniques for miniaturization of the probe. In this MEMS design the mirror will have high fill factor and bonding pads on the opposite chip side of the reflective mirror surface. The MEMS mirror and the other optical component will be packaged into the MEMS-based probe; the probe will be attached with the existing OCT system, and then will be tested for lung imaging. The proposed MEMS-based OCT system has the potential to be a low-cost tool for rapid diagnosis or screening of lung cancer at the point of care. It is also expected that the technology could be used for other OCT systems for internal organ imaging. If successful the proposed MEMS design and wire bonding-free (WBF) packaging technique can be applied virtually to all optical imaging systems including coherence, confocal, nonlinear and adaptive optical imaging. They can also be used in laser scanning displays and optical telecommunications. This effort may lead to the world's first MEMS-based OCT applicable to rapid diagnosis or screening of lung cancer at the point of care (e.g., bedside or office). Due to its low-cost and disposable nature, it is particularly suitable for field use without the need of sterilization equipments. Although the focus of this proposal is on a MEMS based endoscopic OCT system for bronchoscopy, the key technology developed can be adapted for other compact OCT systems for internal organ imaging. The MEMS-based endoscopic OCT probe is applicable to diagnosis and image-guided surgery of various internal cancers such as prostate, colon, rectal, and gastro-intestinal cancers. "This award is funded under the American Recovery and Reinvestment Act of 2009 (Public Law 111-5)."

K
Kjaya

Kjaya is a company that received a SBIR Phase I grant for a project entitled: Semi-Autonomous Adaptive Neural and Genetic Segmentation of Medical Images. Their Phase I project will implement a physician-assisted, real-time adaptive system for the segmentation of anatomical structures in 3D medical image data. Medical image segmentation seeks to change the representation of an anatomical structure, making it more easily analyzed. Because of the extreme variability of these structures in biological systems, current idiosyncratic manual methods currently in use are tedious, time consuming, and error prone. Image segmentation cannot in general be programmatically solved. The proposed system is a Neural Network (NN) based adaptation of the individual data using parallel Graphics Processing Units (GPUs) and coupled with a Genetic Algorithm (GA) based adaptation across GPU cores. The system will build a diagnostically useful segmentation of the anatomical feature within seconds from an area of interest outlined by a physician using a Computed Tomography (CT) or Magnetic Resonance Imaging (MRI) scan. Fast growth in medical imaging overwhelms available diagnosticians. An intuitive and inexpensive system to quickly and accurately deliver diagnostic relevant segmentation of medical images offers tremendous commercial value. Currently, each scan requires approximately 50 minutes of manual preparation. The diagnosis and treatment of an estimated 20 percent of diseases benefit from medical imaging. Newer scanning technologies have increased in resolution, but such techniques have not made segmenting easier or faster. The proposed method will enable more diagnostics to be done with the quality controlled directly by physicians.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.